your market intelligence analyst
Search Results
109 results
Your search is now limited to «Company News in Infectious Diseases» expert search.
PMLiVE 02/25/2020 06:41
Although Gilead allegedly owns all patents for the drug, including for coronaviruses, that did not stop Chinese pharma company BrightGene from successfully copying the drug for use in China.
More from PMLiVE:
Updated Date: Mon, 24 Feb 2020 00:00:00 EST.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
3BL Media 02/14/2020 05:05
From a donation of a million masks to help protect vulnerable healthcare workers to committed research on a potential vaccine, the company has activated quickly in several key ways to help address the outbreak. DESCRIPTION:. In times of need, every bit of help counts. It's something Johnson & Johnson knows well: Throughout its over 130-year history, the company has had a legacy of during times of crisis, from natural disasters to health outbreaks. In response to the current Covid-19 outbreak—which is caused by the coronavirus and continues to spread, with over —the company has mobilized quickly to provide crucial donations from across its businesses, as well as other support, to help those impacted.
Seeking Alpha 02/10/2020 12:23
Furthermore, Gilead's Phase 2 clinical for Ebola, Remdesivir, was administered on a compassionate basis to a human infected with Coronavirus ("nCoV") and improved the patient's condition.
More from Seeking Alpha:
Zero Hedge 02/06/2020 17:35
Wuhan Institute Of Virology And Chinese Army Submit Patent For Gilead Anti-Ebola Drug To Fight Coronavirus. Amid that nCoV-2019, aka novel coronavirus, aka the virus behind the Wuhan Coronavirus epidemic, was (and not just any lab, but the BSL-4 rated "biological weapons" grade well, Wuhan) which was then released accidentally (or not) among the broader population - a thesis which China's to refute even as more emerges by the day - we would like to point out that earlier this week, the Wuhan Institute of Virology, which as the " world's most dangerous pathogens", has jointly with the Military Medicine Institute of the People’s Liberation Army Academy of Military Science, i.e.
ENDPOINTS 02/05/2020 07:28
In a Q4 earnings call, Gilead CEO Daniel O’Day indicated that it may be deployed as an emergency treatment.
More from ENDPOINTS:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications